V
Vijay Singh Gondil
Researcher at Panjab University, Chandigarh
Publications - 36
Citations - 677
Vijay Singh Gondil is an academic researcher from Panjab University, Chandigarh. The author has contributed to research in topics: Silver nanoparticle & Medicine. The author has an hindex of 12, co-authored 31 publications receiving 405 citations. Previous affiliations of Vijay Singh Gondil include Chinese Academy of Sciences & Himachal Pradesh University.
Papers
More filters
Journal ArticleDOI
A novel wound dressing consisting of PVA-SA hybrid hydrogel membrane for topical delivery of bacteriophages and antibiotics.
TL;DR: The dual coated hydrogel membrane delivering both MR10 phage and minocycline proved to be better treatment strategy to treat the resistant burn wound infection rather thanphage and antibiotic alone.
Journal ArticleDOI
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
TL;DR: This review primarily reviews the recent advancements made in the evaluation of therapeutic potential of endolysins, including their origin, host range, applications and synergy with conventional and non conventional antimicrobial agents.
Journal ArticleDOI
A Novel Approach for Combating Klebsiella pneumoniae Biofilm Using Histidine Functionalized Silver Nanoparticles.
Sanjay Chhibber,Vijay Singh Gondil,Samrita Sharma,Munish Kumar,Nishima Wangoo,Rohit K. Sharma +5 more
TL;DR: This is the first study demonstrating the application of amino acid functionalized silver nanoparticles in the eradication of young and old K. pneumoniae biofilm and the lowering of gentamicin dose when used in combination.
Journal ArticleDOI
Encapsulation and Delivery of Therapeutic Phages.
Belinda Loh,Vijay Singh Gondil,Prasanth Manohar,Fazal Mehmood Khan,Hang Yang,Sebastian Leptihn,Sebastian Leptihn +6 more
TL;DR: The issues that are critical for phage therapy to become a reliable standard therapy are focused on and methods for efficient and targeted delivery of phages, including their encapsulation are described.
Journal ArticleDOI
Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections
Vijay Singh Gondil,Taru Dube,Jiban Jyoti Panda,Ragothaman M. Yennamalli,Kusum Harjai,Sanjay Chhibber +5 more
TL;DR: It is confirmed that chitosan nanoparticles are a promising biocompatible candidate for Cpl-1 delivery with a significant potential to increase bioavailability of enzyme that in turn can increase its in-vivo half life to treat S. pneumoniae infections.